Trials / Completed
CompletedNCT03655548
Optimization Management Study of Community Urinary Tract Infections Spectrum
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 108 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Urinary tract infections are the second most common community-acquired infections. Even if extended spectrum β-lactamase-producing Enterobacteriaceae (ESBLE) cause fewer urinary tract infections, their proportion is increasing. New recommendations were published by ANSM in 2015, with specific recommendations for infections due to ESBL-producing Enterobacteriaceae. In this study, we wanted to evaluate the effectiveness of a recall of the 2015 recommendations in the form of a table attached to the ECBU report, associated with hygiene recommendations. Methodology: This prospective, multi-center, non-interventional study was conducted in collaboration with the Labazur laboratory over two 2-month periods, one without modification of the laboratory's practices, the other with the addition of documents on the CBEU report. The primary endpoint was the adequacy of prescriptions to ANSM 2015 recommendations.
Conditions
- Urinary Tract Infections
- Resistant Infection
- Community-Acquired Infections
- Beta Lactam Resistant Bacterial Infection
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-02-28
- Completion
- 2017-02-28
- First posted
- 2018-08-31
- Last updated
- 2018-08-31
Source: ClinicalTrials.gov record NCT03655548. Inclusion in this directory is not an endorsement.